Flexion Therapeutics Inc

Provides critical revenue estimates and analysis for all tax legislation, directly influencing corporate tax structures and investment credits that impact the financial health of pharmaceutical companies.

Controls corporate tax policy, which directly affects profitability, and influences Medicare pricing and trade policies, all of which are critical for the pharmaceutical industry's market and financial health.

Directly allocates federal discretionary spending, including funding for health agencies (FDA, NIH) and purchasers (VA, DOD), which profoundly impacts research, regulatory capacity, and market demand for pharmaceuticals.

Directly regulates the FDA, which is responsible for drug approval and oversight, making it the primary and most critical committee for a pharmaceutical preparation manufacturing company.

Has direct oversight over intellectual property (patents) and antitrust laws, both of which are foundational to the pharmaceutical industry for protecting drug innovations and regulating mergers and acquisitions.